Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Bridgewater, New Jersey 08807


Purpose:

The primary objective of this study is to evaluate the efficacy of SSR240600C in women with overactive bladder compared to placebo using tolterodine as a study calibrator.


Criteria:

Inclusion Criteria: - Diagnosis of overactive bladder Exclusion Criteria: - Stress incontinence or mixed incontinence where stress incontinence is the predominant component based on prior history - Urinary incontinence due to cause other than detrusor overactivity (eg, overflow incontinence) - Current Urinary Tract Infection (UTI) or frequent UTIs - Urinary retention or other evidence of poor detrusor function - Pain during voiding or bladder pain without voiding - History of radiation cystitis or history of pelvic irradiation - History of interstitial cystitis or bladder related pain syndrome The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.


NCT ID:

NCT00564226


Primary Contact:

Study Director
ICD CSD
Sanofi-Aventis


Backup Contact:

N/A


Location Contact:

Bridgewater, New Jersey 08807
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: August 16, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.